4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lung ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator. The company was incorporated in 2012 and is based in Carlton, Australia.
Depending on the exchange, the stock ticker may vary. For instance, on exchange 4DMedical Limited stocks are traded under the ticker MQ7.MU.
When is the next 4DMedical Limited earnings date?▼
4DMedical Limited is going to release the next earnings report on August 27, 2026.
What were 4DMedical Limited earnings last quarter?▼
MQ7.MU earnings for the last quarter are -0.15 EUR per share, whereas the estimation was -0.02 EUR resulting in a -615.47% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does 4DMedical Limited have?▼
As of April 12, 2026, the company has 145 employees.
In which sector is 4DMedical Limited located?▼
4DMedical Limited operates in the Health & Wellness sector.
When did 4DMedical Limited complete a stock split?▼
4DMedical Limited has not had any recent stock splits.
Where is 4DMedical Limited headquartered?▼
4DMedical Limited is headquartered in Carlton, United States.